ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Quince Therapeutics Inc

Quince Therapeutics Inc (QNCX)

1.70
0.16
(10.39%)
Closed November 09 3:00PM
1.7328
0.0328
(1.93%)
After Hours: 6:00PM

Quince Therapeutics Inc Financial Summary

The current QNCX market cap is 74.99M. The company's latest EPS is USD -0.7252 and P/E is -2.33.

Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 00000
Operating Income -5.58M-6.16M-9.92M-11.22M-28.19M
Net Income -4.89M-5.35M-8.89M-11.15M-27.73M
Year End December 30 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 00000
Operating Income -39.17M-78.89M-90.32M-52.02M-34.62M
Net Income -36.98M-76.85M-89.95M-51.66M-31.39M
Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 88.84M85.39M167.9M159.29M134.83M
Total Liabilities 1.95M2.25M82.82M85.12M87.86M
Total Equity 86.88M83.13M85.08M74.18M46.97M
Year End December 30 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 124.37M189.47M133.23M103.91M167.9M
Total Liabilities 8.89M17.2M14.64M3.32M82.82M
Total Equity 115.48M172.26M118.59M100.59M85.08M
Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -7.4M-12.21M-18.29M-8.35M-17.09M
Investing -14.78M-11.15M-5.76M8.91M3.94M
Financing 76k86k143k190k225k
Year End December 30 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -33.28M-50.82M-62.93M-44.04M-18.29M
Investing -17.75M-52.43M58.95M18M-5.76M
Financing 77.37M118.88M6.81M707k143k
Market Cap 74.99M
Price to Earnings Ratio -2.33
Price to Sales Ratio 0
Price to Cash Ratio 3.52
Price to Book Ratio 0.86
Dividend Yield -

Share Statistics

Shares Outstanding 43.28M
Average Volume (1 week) 335.69k
Average Volume (1 Month) 1.3M
52 Week Change 86.32%
52 Week High 1.79
52 Week Low 0.5116
Spread (Intraday) 0.16 (9.2%)

Company Info

Company Name Quince Therapeutics Inc
Address 1209 orange street
wilmington, delaware 19801
Website https://quincetx.com
Industry biological pds,ex diagnstics (2836)

Your Recent History

Delayed Upgrade Clock